{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:08:58Z","timestamp":1789088938793,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2024XY068"],"award-info":[{"award-number":["2024XY068"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00874-5","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:46:24Z","timestamp":1782452784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TrxR1 inhibition sensitizes hepatocellular carcinoma to Motesanib via an autophagy-ROS-JNK\/ER stress axis"],"prefix":"10.1186","volume":"21","author":[{"given":"Shengwei","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peisen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guorong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanbin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"issue":"3","key":"874_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA-CANCER J CLIN. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA-CANCER J CLIN"},{"issue":"suppl","key":"874_CR2","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.3350\/cmh.2022.0424","volume":"29","author":"SK Han","year":"2023","unstructured":"Han SK, Baik SK, Kim MY. Non-alcoholic fatty liver disease: Definition and subtypes. CLIN MOL HEPATOL. 2023;29(suppl):S5\u201316. https:\/\/doi.org\/10.3350\/cmh.2022.0424.","journal-title":"CLIN MOL HEPATOL"},{"issue":"1","key":"874_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00423-020-02052-1","volume":"406","author":"J Bednarsch","year":"2021","unstructured":"Bednarsch J, Czigany Z, Heise D, Joechle K, Luedde T, Heij L, Bruners P, Ulmer TF, Neumann UP, Lang SA. Prognostic evaluation of HCC patients undergoing surgical resection: an analysis of 8 different staging systems. Langenbeck\u2019s archives Surg. 2021;406(1):75\u201386. https:\/\/doi.org\/10.1007\/s00423-020-02052-1.","journal-title":"Langenbeck\u2019s archives Surg"},{"issue":"4","key":"874_CR4","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s12029-020-00486-w","volume":"51","author":"F \u00d6zdemir","year":"2020","unstructured":"\u00d6zdemir F, Baskiran A. The Importance of AFP in Liver Transplantation for HCC. J GASTROINTEST CANC. 2020;51(4):1127\u201332. https:\/\/doi.org\/10.1007\/s12029-020-00486-w.","journal-title":"J GASTROINTEST CANC"},{"issue":"1","key":"874_CR5","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/cancers13010104","volume":"13","author":"P Habibollahi","year":"2020","unstructured":"Habibollahi P, Sheth RA, Cressman ENK. Histological Correlation for Radiofrequency and Microwave Ablation in the Local Control of Hepatocellular Carcinoma (HCC) before Liver Transplantation. Compr Rev CANCERS. 2020;13(1):104. https:\/\/doi.org\/10.3390\/cancers13010104.","journal-title":"Compr Rev CANCERS"},{"issue":"2","key":"874_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","volume":"82","author":"AFTS European","year":"2025","unstructured":"European AFTS. EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma. J HEPATOL. 2025;82(2):315\u201374. https:\/\/doi.org\/10.1016\/j.jhep.2024.08.028.","journal-title":"J HEPATOL"},{"issue":"3","key":"874_CR7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s10555-023-10084-4","volume":"42","author":"Y Wang","year":"2023","unstructured":"Wang Y, Deng B. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers. Cancer Metastasis Rev. 2023;42(3):629\u201352. https:\/\/doi.org\/10.1007\/s10555-023-10084-4.","journal-title":"Cancer Metastasis Rev"},{"issue":"4","key":"874_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1159\/000538815","volume":"42","author":"A Teufel","year":"2024","unstructured":"Teufel A, Kudo M, Qian Y, Daza J, Rodriguez I, Reissfelder C, Ridruejo E, Ebert MP, Basel. Switzerland). 2024;42(4):349\u201360. https:\/\/doi.org\/10.1159\/000538815.","journal-title":"Switzerland)"},{"issue":"2","key":"874_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1053\/j.seminoncol.2014.02.007","volume":"41","author":"K Mittal","year":"2014","unstructured":"Mittal K, Ebos J, Rini B. Angiogenesis and the tumor microenvironment: vascular endothelial growth factor and beyond. SEMIN ONCOL. 2014;41(2):235\u201351. https:\/\/doi.org\/10.1053\/j.seminoncol.2014.02.007.","journal-title":"SEMIN ONCOL"},{"issue":"6","key":"874_CR10","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","volume":"176","author":"RS Apte","year":"2019","unstructured":"Apte RS, Chen DS, Ferrara N. VEGF in Signaling and Disease: Beyond Discovery and Development. Cell. 2019;176(6):1248\u201364. https:\/\/doi.org\/10.1016\/j.cell.2019.01.021.","journal-title":"Cell"},{"issue":"6","key":"874_CR11","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.3390\/ijms26062386","volume":"26","author":"Z Yao","year":"2025","unstructured":"Yao Z, Li J, Yu J, Cheng Y, Fang C, Chen X, Chen X, Wang Y, Gao D, Lin F. Glycometabolic Regulation of Angiogenesis: Mechanisms and Therapeutic Strategies. Int J Mol Sci. 2025;26(6):2386. https:\/\/doi.org\/10.3390\/ijms26062386.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"874_CR12","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10456-014-9420-y","volume":"17","author":"NS Vasudev","year":"2014","unstructured":"Vasudev NS, Reynolds AR. Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions. Angiogenesis. 2014;17(3):471\u201394. https:\/\/doi.org\/10.1007\/s10456-014-9420-y.","journal-title":"Angiogenesis"},{"key":"874_CR13","doi-asserted-by":"publisher","unstructured":"Roy S, Kumaravel S, Sharma A, Duran CL, Bayless KJ, Chakraborty S. Hypoxic tumor microenvironment: implications for cancer therapy. Exp Biol Med (Maywood). 2020;245(13):1073\u20131086. https:\/\/doi.org\/10.1177\/1535370220934038.","DOI":"10.1177\/1535370220934038"},{"issue":"11","key":"874_CR14","doi-asserted-by":"publisher","first-page":"105291","DOI":"10.1016\/j.jbc.2023.105291","volume":"299","author":"N Downes","year":"2023","unstructured":"Downes N, Niskanen H, Bosch T, Taipale V, Godiwala M, V\u00e4\u00e4n\u00e4nen M, Turunen MRA, Aavik TA, Laham-Karam E, Yl\u00e4-Herttuala N, Kaikkonen S. Hypoxic regulation of hypoxia inducible factor 1 alpha via antisense transcription. J Biol Chem. 2023;299(11):105291. https:\/\/doi.org\/10.1016\/j.jbc.2023.105291.","journal-title":"J Biol Chem"},{"issue":"10","key":"874_CR15","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3390\/antiox14101187","volume":"14","author":"JS Ranbhise","year":"2025","unstructured":"Ranbhise JS, Singh MK, Ju S, Han S, Yun HR, Kim SS, Kang I. The Redox Paradox: Cancer\u2019s Double-Edged Sword for Malignancy and Therapy. ANTIOXIDANTS-BASEL. 2025;14(10):1187. https:\/\/doi.org\/10.3390\/antiox14101187.","journal-title":"ANTIOXIDANTS-BASEL"},{"key":"874_CR16","doi-asserted-by":"publisher","unstructured":"Liang Y, Lan H, Li Q, Gao M, Liu M, Xu Z, Gao Y, Zhang L, Li Y, Zhao B. Exploiting metabolic vulnerabilities through synergistic ferroptosis and disulfidptosis for breast cancer therapy. J Adv Res. 2025:S1232-S2090. https:\/\/doi.org\/10.1016\/j.jare.2025.03.052.\u00a0","DOI":"10.1016\/j.jare.2025.03.052"},{"issue":"5","key":"874_CR17","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison BR, Stockwell BR. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042.","journal-title":"Cell"},{"issue":"9","key":"874_CR18","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/mc.23436","volume":"61","author":"A Passaniti","year":"2022","unstructured":"Passaniti A, Kim MS, Polster BM, Shapiro P. Targeting mitochondrial metabolism for metastatic cancer therapy. MOL CARCINOGEN. 2022;61(9):827\u201338. https:\/\/doi.org\/10.1002\/mc.23436.","journal-title":"MOL CARCINOGEN"},{"key":"874_CR35","doi-asserted-by":"publisher","unstructured":"Muri J, Heer S, Matsushita M, Pohlmeier L, Tortola L,Fuhrer T, et al. The thioredoxin-1 system is essential for fueling DNA synthesis during T-cell metabolic reprogramming and proliferation. Nat Commun. 2018;9(1):1851. https:\/\/doi.org\/10.1038\/s41467-018-04274-w.","DOI":"10.1038\/s41467-018-04274-w"},{"issue":"9","key":"874_CR20","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1158\/0008-5472.CAN-13-2033","volume":"74","author":"W Fiskus","year":"2014","unstructured":"Fiskus W, Saba N, Shen M, Ghias M, Liu J, Gupta SD, Chauhan L, Rao R, Gunewardena S, Schorno K, Austin CP, Maddocks K, Byrd J, Melnick A, Huang P, Wiestner A, Bhalla KN. Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemia. CANCER RES. 2014;74(9):2520\u201332. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-2033.","journal-title":"CANCER RES"},{"issue":"10","key":"874_CR21","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3390\/antiox13101201","volume":"13","author":"F Jamali","year":"2024","unstructured":"Jamali F, Lan K, Daniel P, Petrecca K, Sabri S, Abdulkarim B. Synergistic Dual Targeting of Thioredoxin and Glutathione Systems Irrespective of p53 in Glioblastoma Stem Cells. ANTIOXIDANTS-BASEL. 2024;13(10):1201. https:\/\/doi.org\/10.3390\/antiox13101201.","journal-title":"ANTIOXIDANTS-BASEL"},{"issue":"21","key":"874_CR22","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.3390\/cancers15215136","volume":"15","author":"FH Abdalbari","year":"2023","unstructured":"Abdalbari FH, Martinez-Jaramillo E, Forgie BN, Tran E, Zorychta E, Goyeneche AA, Sabri S, Telleria CM. Auranofin Induces Lethality Driven by Reactive Oxygen Species in High-Grade Serous Ovarian Cancer Cells. CANCERS. 2023;15(21):5136. https:\/\/doi.org\/10.3390\/cancers15215136.","journal-title":"CANCERS"},{"issue":"2","key":"874_CR23","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method. CANCER RES. 2010;70(2):440\u20136. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1947.","journal-title":"CANCER RES"},{"issue":"1","key":"874_CR24","doi-asserted-by":"publisher","first-page":"249","DOI":"10.7150\/ijbs.86160","volume":"20","author":"P Zheng","year":"2024","unstructured":"Zheng P, Xia Y, Shen X, Lu H, Chen Y, Xu C, Qiu C, Zhang Y, Zou P, Cui R, Huang X. Combination of TrxR1 inhibitor and lenvatinib triggers ROS-dependent cell death in human lung cancer cells. INT J BIOL SCI. 2024;20(1):249\u201364. https:\/\/doi.org\/10.7150\/ijbs.86160.","journal-title":"INT J BIOL SCI"},{"issue":"11","key":"874_CR25","doi-asserted-by":"publisher","first-page":"837","DOI":"10.15252\/msb.20156269","volume":"11","author":"AS Zeke","year":"2015","unstructured":"Zeke AS, Bastys T, Alexa A, Garai \u00c1, M\u00e9sz\u00e1ros BL, Kirsch KR, Doszt\u00e1nyi Z, Kalinina OV, Rem\u00e9nyi A. Systematic discovery of linear binding motifs targeting an ancient protein interaction surface on MAP kinases. MOL SYST BIOL. 2015;11(11):837. https:\/\/doi.org\/10.15252\/msb.20156269.","journal-title":"MOL SYST BIOL"},{"issue":"17","key":"874_CR26","doi-asserted-by":"publisher","first-page":"8715","DOI":"10.1158\/0008-5472.CAN-05-4665","volume":"66","author":"A Polverino","year":"2006","unstructured":"Polverino A, Coxon A, Starnes C, Diaz Z, DeMelfi T, Wang L, Bready J, Estrada J, Cattley R, Kaufman S, Chen D, Gan Y, Kumar G, Meyer J, Neervannan S, Alva G, Talvenheimo J, Montestruque S, Tasker A, Patel V, Radinsky R, Kendall R. AMG 706, an oral, multikinase inhibitor that selectively targets vascular endothelial growth factor, platelet-derived growth factor, and kit receptors, potently inhibits angiogenesis and induces regression in tumor xenografts. CANCER RES. 2006;66(17):8715\u201321. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-4665.","journal-title":"CANCER RES"},{"issue":"1","key":"874_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1158\/1078-0432.CCR-22-1366","volume":"29","author":"SA Patel","year":"2023","unstructured":"Patel SA, Nilsson MB, Le X, Cascone T, Jain RK, Heymach JV. Molecular Mechanisms and Future Implications of VEGF\/VEGFR in Cancer Therapy. Clin cancer research: official J Am Association Cancer Res. 2023;29(1):30\u20139. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-1366.","journal-title":"Clin cancer research: official J Am Association Cancer Res"},{"issue":"34","key":"874_CR28","doi-asserted-by":"publisher","first-page":"36505","DOI":"10.18632\/oncotarget.5364","volume":"6","author":"P Zou","year":"2015","unstructured":"Zou P, Chen M, Ji J, Chen W, Chen X, Ying S, Zhang J, Zhang Z, Liu Z, Yang S, Liang G. Auranofin induces apoptosis by ROS-mediated ER stress and mitochondrial dysfunction and displayed synergistic lethality with piperlongumine in gastric cancer. Oncotarget. 2015;6(34):36505\u201321. https:\/\/doi.org\/10.18632\/oncotarget.5364.","journal-title":"Oncotarget"},{"issue":"8","key":"874_CR29","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","volume":"12","author":"W Hou","year":"2016","unstructured":"Hou W, Xie Y, Song X, Sun X, Lotze MT, Zeh HJR, Kang R, Tang D. Autophagy promotes ferroptosis by degradation of ferritin. AUTOPHAGY. 2016;12(8):1425\u20138. https:\/\/doi.org\/10.1080\/15548627.2016.1187366.","journal-title":"AUTOPHAGY"},{"issue":"20","key":"874_CR30","doi-asserted-by":"publisher","first-page":"13291","DOI":"10.1074\/jbc.R900010200","volume":"284","author":"T Nguyen","year":"2009","unstructured":"Nguyen T, Nioi P, Pickett CB. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J BIOL CHEM. 2009;284(20):13291\u20135. https:\/\/doi.org\/10.1074\/jbc.R900010200.","journal-title":"J BIOL CHEM"},{"key":"874_CR31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.freeradbiomed.2021.10.020","volume":"177","author":"M Delgobo","year":"2021","unstructured":"Delgobo M, Gon\u00e7alves RNM, Delazeri MANO, Falchetti M, Zandon\u00e1 A, Das Neves N, Almeida R, Fagundes K, Gelain AC, Fracasso DP, Mac\u00eado JOI, Priori GBD, Bassani L, Bishop N, Forcelini AJR, Moreira CM, Zanotto-Filho JCUF. Thioredoxin reductase-1 levels are associated with NRF2 pathway activation and tumor recurrence in non-small cell lung cancer. FREE RADICAL BIO MED. 2021;177:58\u201371. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.10.020.","journal-title":"FREE RADICAL BIO MED"},{"key":"874_CR32","doi-asserted-by":"publisher","unstructured":"Fu B, Meng W, Zeng X, Zhao H, Liu W, Zhang T. TXNRD1 is an unfavorable prognostic factor for patients with hepatocellular carcinoma. Biomed Res Int. 2017;2017:4698167. https:\/\/doi.org\/10.1155\/2017\/4698167.","DOI":"10.1155\/2017\/4698167"},{"key":"874_CR33","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3389\/fonc.2018.00611","volume":"8","author":"L Tuo","year":"2018","unstructured":"Tuo L, Xiang J, Pan X, Gao Q, Zhang G, Yang Y, Liang L, Xia J, Wang K, Tang N. PCK1 Downregulation Promotes TXNRD1 Expression and Hepatoma Cell Growth via the Nrf2\/Keap1 Pathway. FRONT ONCOL. 2018;8:611. https:\/\/doi.org\/10.3389\/fonc.2018.00611.","journal-title":"FRONT ONCOL"},{"issue":"10","key":"874_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0159-1","volume":"50","author":"C M\u00e9ndez-Blanco","year":"2018","unstructured":"M\u00e9ndez-Blanco C, Fondevila F, Garc\u00eda-Palomo AS, Gonz\u00e1lez-Gallego J, Mauriz JL. Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors. EXP MOL MED. 2018;50(10):1\u20139. https:\/\/doi.org\/10.1038\/s12276-018-0159-1.","journal-title":"EXP MOL MED"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00874-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00874-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00874-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:26:24Z","timestamp":1789086384000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00874-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["874"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00874-5","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"2 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal study protocol was approved by the Ethics Committee of Wenzhou Medical University (Approval code: KY2022-R130; Approval date: 14 August 2022). All animal experiments were conducted in accordance with institutional animal ethics requirements and reported following the ARRIVE guidelines.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"172"}}